Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

qcr-holdings-stock-gains-support-from-stephens-coverage-and-dividend-increase

QCR Holdings stock gains support from Stephens coverage and dividend increase

Sep 19, 2026

QCR Holdings, Inc. stock (ISIN US74729G1004) is trading near the upper end of its recent range, supported by…

Read more
micron-technology-(mu)-stock-forecast-and-price-target-2026-$mu

Micron Technology (MU) Stock Forecast and Price Target 2026 $MU

Sep 18, 2026

Micron Technology – Analysts’ Recommendations and Stock Price Forecast (2026) Consensus Rating Based on 38 Wall Street analysts…

Read more
this-cue-biopharma-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-friday

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Sep 18, 2026

Please enable cookies. You are unable to access benzinga.com Why have I been blocked? This website is using…

Read more
rodman-and-renshaw-initiates-analyst-coverage-on-quantum-biopharma-with-a-buy-rating-and-us$8-price-target

Rodman and Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target

Sep 18, 2026

TORONTO – Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (‘Quantum BioPharma‘ or the ‘Company’), a biopharmaceutical company dedicated…

Read more
how-investors-may-respond-to-five9-(fivn)-analyst-starts-coverage

How Investors May Respond To Five9 (FIVN) Analyst Starts Coverage

Sep 18, 2026

FBN Securities recently began covering Five9, highlighting how the company is leaning further into AI-powered customer experience software…

Read more
rodman-&-renshaw-initiates-analyst-coverage-on-quantum-biopharma-with-a-buy-rating-and-us$8-price-target

Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target

Sep 18, 2026

This is a paid press release. Contact the press release distributor directly with any inquiries. Quantum BioPharma Thu,…

Read more
3-stocks-worth-watching-following-new-analyst-coverage

3 Stocks Worth Watching Following New Analyst Coverage

Sep 18, 2026

Shrabana Mukherjee Thu, September 17, 2026 at 1:42 PM EDT 4 min read The U.S. economy remains resilient,…

Read more
3-stocks-worth-watching-following-new-analyst-coverage

3 Stocks Worth Watching Following New Analyst Coverage

Sep 17, 2026

The U.S. economy remains resilient, supported by steady consumer spending, healthy employment and continued business investment. However, persistent…

Read more
b.riley-initiates-nokia-stock-coverage-with-buy-rating-on-ai-growth

B.Riley initiates Nokia stock coverage with buy rating on AI growth

Sep 17, 2026

B.Riley initiates Nokia stock coverage with buy rating on AI growth

Read more
fox-corporation-stock-dips-as-insider-deal-and-analyst-coverage-reshape-outlook

Fox Corporation stock dips as insider deal and analyst coverage reshape outlook

Sep 17, 2026

Fox Corporation stock (ISIN US35137L1052) closed at USD 66.16 on Nasdaq on September 16, 2026, down 2.09% from…

Read more
sitime-jumps-as-fresh-analyst-coverage-adds-to-ai-and-timing-growth-story

SiTime Jumps as Fresh Analyst Coverage Adds to AI and Timing Growth Story

Sep 17, 2026

SiTime Corporation (SITM) is up 9.6% today. Here is some analysis on what might have caused this price…

Read more
wolfe-research-begins-coverage-on-zymeworks-(nasdaq:zyme)

Wolfe Research Begins Coverage on Zymeworks (NASDAQ:ZYME)

Sep 17, 2026

Wolfe Research started coverage on shares of Zymeworks (NASDAQ:ZYME – Get Free Report) in a research report issued…

Read more
  1. Pages:
  2. «
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. ...
  11. 475
  12. »

Posts pagination

Newer posts Page 1 … Page 4 … Page 475 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.